How did Bausch & Lomb's revenue and expenses trend in Q4 2024?

Bausch & Lomb's revenue and expenses in Q4 2024 showed a mixed trend across different business segments:

1. **Revenue Trend**:
- The company's total revenue for the quarter was $1.8 billion.
- Breaking down by segment, the revenue was as follows: $1.72 billion from the Over The Counter segment, $1.32 billion from the Devices segment, $1.26 billion from the Pharmaceuticals segment, and $969 million from the Branded and Other Generics segment.
2. **Expense Trend**:
- The net income for Q4 2024 was -$2 million, indicating a loss for the period.
- Operating expenses are not provided, but the net loss of $2 million suggests that the expenses were higher than the revenue in this segment.
3. **Segment Performance**:
- The Devices segment contributed the most to the revenue, followed by the Over The Counter and Pharmaceuticals segments.
- The Branded and Other Generics segment had the lowest revenue among the segments.
4. **Overall Financial Health**:
- The negative net income suggests that Bausch & Lomb's expenses exceeded its revenue in Q4 2024, leading to a financial loss for the period.

In conclusion, Bausch & Lomb faced a challenging quarter in Q4 2024, with revenues crossing the billion mark but falling short in terms of profitability, resulting in a net loss.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Other|1.7E7|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Other|1.2E7|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Other|8000000|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Other|5000000|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Branded and Other Generics|6.6E7|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Pharmaceuticals|2.09E8|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Over The Counter|3.95E8|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Other|5000000|169|
|BLCO|BLCO.N|Bausch + Lomb|20240101-2024|Devices|4.24E8|169|

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|BLCO|BLCO.N|Bausch + Lomb|2024 Q1|-85.22727272727273|-1.63E8|169|
|BLCO|BLCO.N|Bausch + Lomb|2024 Q2|-410.3448275862069|-1.48E8|169|
|BLCO|BLCO.N|Bausch + Lomb|2024 Q3|110.00000000000001|8000000|169|
|BLCO|BLCO.N|Bausch + Lomb|2024 Q4|96.07843137254902|-2000000|169|